Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2020

Feb 14, 2020

30237_dirs_2020-02-14_1ba67cba-ea85-4782-b101-ce3f0b6ce937.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-12

Reporting Person: EISENBERG GLENN A (Chief Financial Officer, EVP)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-12 Common Stock M 780 Acquired 18538 Direct
2020-02-12 Common Stock F 232 $187.51 Disposed 18306 Direct
2020-02-12 Common Stock M 940 Acquired 19246 Direct
2020-02-12 Common Stock F 280 $187.51 Disposed 18966 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-12 Restricted Stock Unit $ M 780 Disposed Common Stock (780) Direct
2020-02-12 Restricted Stock Unit $ M 940 Disposed Common Stock (940) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.